The groundbreaking TIM-3 Alzheimer’s therapy represents a significant leap forward in the quest for effective treatments for Alzheimer’s disease, targeting the intricate interplay between immunity and cognitive health.By investigating the TIM-3 checkpoint molecule, researchers have discovered a way to unleash microglia, the brain's immune cells, allowing them to attack the harmful plaques that contribute to cognitive decline in Alzheimer’s patients.